Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern

PHASE2CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

March 16, 2018

Primary Completion Date

December 22, 2019

Study Completion Date

January 4, 2020

Conditions
Epilepsy
Interventions
DRUG

Staccato Alprazolam

single dose for inhalation

DRUG

Placebos

single dose for inhalation

Trial Locations (67)

3004

The Alfred, Melbourne

3050

The Royal Melbourne Hospital, Melbourne

3084

Austin Hospital, Heidelberg

10016

NYU Comprehensive Epilepsy Center, New York

10029

Mount Sinai Health System, New York

10075

Lenox Hill Hospital, New York

11203

SUNY Downstate Medical Center - Comprehensive Epilepsy Center, Brooklyn

14203

Kaleida Health Oishei Children's Hospital, Buffalo

14226

Dent Neurologic Institute, Amherst

14642

University of Rochester Medical Center, Rochester

15213

University of Pittsburgh Medical Center, Pittsburgh

19104

University of Pennsylvania, Philadelphia

19107

Thomas Jefferson University, Philadelphia

19140

Lewis Katz School of Medicine at Template University, Philadelphia

20007

Georgetown University Hospital, Washington D.C.

20037

GW Medical Faculty Associates, Washington D.C.

20817

Mid-Atlantic Epilepsy And Sleep Center, LLC, Bethesda

24014

Carilion Roanoke Memorial Hospital, Roanoke

24502

Centra Medical Group Neurology Center, Lynchburg

28025

OnSite Clinical Solutions, LLC, Concord

28207

Carolinas Neurosciences Institute, Charlotte

30093

Center for Rare Neurological Diseases, Norcross

30281

Clinical Research Institute, Stockbridge

32209

University of Florida Health Science Center Jacksonville, Jacksonville

32224

Mayo Clinic Florida, Jacksonville

32561

NW FL Clinical Research Group LLC, Gulf Breeze

32803

AdventHealth Orlando, Orlando

32806

Research Institute of Orlando, LLC, Orlando

33136

Clinical Translational Research Site, Miami

33147

Advanced Pharma Cr, LLC, Miami

33155

Nicklaus Children's Hospital, Miami

33607

NeuroMedical Research Institute, Panama City

35294

UAB Hospital, Birmingham

43606

The Promedica-University of Toledo Neuroscience Center, Toledo

48109

University of Michigan, Ann Arbor

48322

SRI International, West Bloomfield

49007

Bronson Methodist Hospital, Kalamazoo

60611

Northwestern Memorial Hospital, Chicago

60612

Rush University Medical Center, Chicago

63110

Washington University School of Medicine, St Louis

66160

University of Kansas Medical Center, Kansas City

70121

Ochsner Health System, New Orleans

72205

Clinical Trials Inc, Little Rock

75390

University of Texas Southwestern Medical Center - Neurology Clinic, Dallas

77030

UT Houston, Houston

77074

Clinical Trial Network, Houston

80045

University of Colorado, Aurora

84132

University of Utah Hospital, Salt Lake City

85006

University of Arizona, Phoenix

85013

St. Joseph's Hospital and Medical Center - Barrow Neurological Institute, Phoenix

89106

Impact Clinical Trials Las Vegas, Las Vegas

90095

UCLA, Los Angeles

90242

Rancho Research Institute Inc., Downey

91105

Havana Research Institute LLC., Pasadena

92663

Hoag Hospital, Newport Beach

94304

Stanford Neuroscience Health Center, Palo Alto

96817

Hawaii Pacific Neuroscience, Honolulu

97239

Oregon Health & Science University - Brain Institute - Comprehensive Epilepsy Center, Portland

98405

Multi-Care Institute for Research and Innovation, Tacoma

06511

Yale University, New Haven

06516

VA Connecticut Healthcare System, West Haven

04074

Maine Medical Center, Scarborough

02115

Harvard Medical School - Brigham and Women's Hospital, Boston

08820

JFK Medical Center, Edison

07039

Institute of Neurology & Neurosurgery at St. Barnabas, Livingston

08901

Rutgers University, New Brunswick

Unknown

The Tower, Kingston

Sponsors
All Listed Sponsors
lead

Engage Therapeutics, Inc.

INDUSTRY

NCT03478982 - Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern | Biotech Hunter | Biotech Hunter